Facebook tracking pixel
N63.2
ICD-10-CM
Breast Lump Left

Concerned about a breast lump left? Find information on left breast mass diagnosis, including clinical documentation, medical coding, and healthcare resources for palpable mass in left breast. Learn about evaluation and management of a left breast mass and relevant medical terminology for accurate clinical documentation.

Also known as

Left Breast Mass
Palpable Mass in Left Breast

Diagnosis Snapshot

Key Facts
  • Definition : A palpable abnormality detected in the left breast tissue.
  • Clinical Signs : May include a noticeable lump, breast pain, nipple discharge, or skin changes.
  • Common Settings : Primary care, breast clinics, imaging centers (mammography, ultrasound).

Related ICD-10 Code Ranges

Complete code families applicable to AAPC N63.2 Coding
N00-N99

Diseases of the genitourinary system

Includes diseases of the female genital organs like breast lumps.

D24

Benign neoplasm of breast

Covers benign growths or tumors in the breast tissue.

R92

Abnormal findings in breast imaging

Includes unusual results from mammograms or other breast scans.

C50

Malignant neoplasm of breast

Classifies cancerous tumors found in the breast.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the breast lump inflammatory?

  • Yes

    Is it acute mastitis?

  • No

    Is the lump specified as diffuse?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Lump in the left breast
Lump in the right breast
Nipple discharge left breast

Documentation Best Practices

Documentation Checklist
  • Document lump size, shape, and location.
  • Note mobility, tenderness, and skin changes.
  • Describe any nipple discharge: color, consistency.
  • Record patient history, including family history of breast cancer.
  • Include imaging results (mammogram, ultrasound).

Coding and Audit Risks

Common Risks
  • Laterality Specificity

    Coding and documentation must clearly specify the left breast to avoid ambiguity and ensure accurate reimbursement. Missing laterality can lead to coding errors.

  • Mass Characterization

    Insufficient documentation of the mass characteristics (e.g., size, shape, texture) can hinder accurate code assignment and impact clinical decision-making.

  • Differential Diagnosis

    Lack of documentation regarding other potential diagnoses considered (differential diagnosis) may raise audit flags and affect the medical necessity of further workup.

Mitigation Tips

Best Practices
  • Complete breast exam: document size, shape, mobility.
  • Image left breast: mammogram, ultrasound, or MRI.
  • Assess lymph nodes: axillary, supraclavicular, infraclavicular.
  • Biopsy if indicated: FNA, core needle, or excisional.
  • Correlate imaging & pathology: ensure accurate ICD-10 coding.

Clinical Decision Support

Checklist
  • Confirm laterality: Is lump truly on LEFT breast? Document location.
  • Characterize lump: Size, shape, mobility, tenderness. Code findings.
  • Assess for nipple discharge: Document color, consistency, spontaneity.
  • Review patient history: Prior breast issues, family history. Code accurately.
  • Order appropriate imaging: Mammogram, ultrasound. Document reason.

Reimbursement and Quality Metrics

Impact Summary
  • Diagnosis: Breast Lump Left (ICD-10 N80.1, ICD-10 N61, others - coding accuracy crucial for reimbursement)
  • Impact: Accurate coding maximizes reimbursement for breast lump evaluations.
  • Impact: Proper documentation impacts quality metrics for breast cancer screening/diagnosis.
  • Impact: Affects hospital reporting on breast health initiatives and resource allocation.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes for . Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What is the recommended diagnostic workup for a palpable, non-tender left breast mass in a premenopausal woman, considering both benign and malignant differentials?

A: The diagnostic workup for a palpable, non-tender left breast mass in a premenopausal woman should consider both benign and malignant etiologies. It typically begins with a thorough clinical breast exam followed by imaging studies. Mammography is usually the first-line imaging modality, though ultrasound is often preferred in younger women due to its greater sensitivity in dense breast tissue. If the mammogram or ultrasound findings are suspicious or indeterminate, further investigation with a core needle biopsy is warranted to obtain a definitive diagnosis. Explore how incorporating standardized diagnostic pathways can improve the efficiency and accuracy of breast mass evaluation. The specific workup may be tailored based on patient age, family history, and other individual risk factors. Consider implementing risk stratification tools to guide decision-making in these cases.

Q: How can I differentiate between a fibroadenoma, cyst, and breast cancer in a patient presenting with a left breast lump based on imaging characteristics (mammogram and ultrasound) and physical exam findings?

A: Differentiating a fibroadenoma, cyst, and breast cancer based on imaging and physical exam findings requires careful consideration of several factors. Fibroadenomas typically present as well-circumscribed, solid, mobile masses on both palpation and ultrasound. Mammographically, they appear as round or oval densities. Cysts are usually palpable as fluctuant, mobile masses and appear anechoic (dark) with posterior acoustic enhancement on ultrasound. Mammographically, they may appear as circumscribed masses or may not be visible at all. Breast cancer can present with a variety of imaging findings, but suspicious features include irregular shape, spiculated margins, and microcalcifications on mammography, and irregular shape, hypoechogenicity, and posterior shadowing on ultrasound. Physical exam findings suggestive of malignancy include a hard, fixed, non-tender mass with skin changes or lymphadenopathy. Learn more about the BI-RADS classification system for standardizing breast imaging interpretation and improving diagnostic accuracy. While these characteristics can help guide the initial assessment, biopsy remains the gold standard for definitive diagnosis.

Quick Tips

Practical Coding Tips
  • Code laterality (left breast)
  • Rule out malignancy (ICD-10)
  • Document lump characteristics
  • Consider imaging codes (ultrasound)
  • Check N12.3 ICD-10 guidance

Documentation Templates

Patient presents with a palpable mass in the left breast, prompting evaluation for a left breast lump.  Chief complaint includes discovery of a left breast mass.  On physical examination, a distinct lump is palpated in the left breast.  Location, size, shape, consistency (e.g., firm, mobile, fixed), and tenderness of the left breast mass are documented.  Assessment includes consideration of differential diagnoses such as fibroadenoma, cyst, and breast cancer.  Patient history includes relevant details regarding menstrual history, hormone use, family history of breast cancer, and prior breast biopsies.  Diagnostic workup may include mammogram, breast ultrasound, and or breast biopsy to evaluate the left breast lump and rule out malignancy.  Treatment plan will be determined based on the results of diagnostic imaging and biopsy, and may include observation, surgical excision, or other appropriate medical management.  Patient education provided regarding breast self-examination, follow-up care, and the importance of regular breast screenings.  ICD-10 codes and CPT codes for evaluation and management of left breast mass, diagnostic imaging, and potential procedures will be documented for medical billing and coding purposes.  This documentation is for electronic health record (EHR) use and supports accurate clinical documentation for patient care and healthcare reimbursement.
Breast Lump Left - AI-Powered ICD-10 Documentation